Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,041.3
-79.3 (-2.54%)

 

  • STI Straits Times Index
    3,041.3
    -79.3 (-2.54%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,514.0
    3.4 (0.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,475.3
    -377.0 (-1.58%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,563.9
    1.2 (0.03%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,821.8
    -462.2 (-1.63%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,533.9
    -74.4 (-1.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,947.1M
  • Value: 3,865.3M
  • Rise: 100
  • Fall: 254
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Lippo Malls Tr0.054-
Singtel2.360-0.050
Sembcorp Marine0.085+0.002
Genting Sing0.770-0.020
Medtecs Intl0.440-0.060
HGH0.020+0.001
ComfortDelGro1.370-0.060
CapLand IntCom T2.110-0.030
Ascendas Reit2.920-0.070
ThaiBev0.670-0.015

World Indices

World Indices
Name Last Change
Nasdaq 15,782.8 +291.2
HSI 23,475.3 -377.0
HSCEI 8,368.5 -129.8
Jakarta 6,533.9 -74.4
Nikkei 225 27,821.8 -462.2
SSE Comp 3,563.9 +1.2
Shanghai A 3,735.2 +1.3
Shanghai B 279.4 -1.1
KOSPI 2,839.0 -70.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CRYO-CELL INTERNATIONAL INC CRYO-CELL INTERNATIONAL
Updated on 29 Nov 2021 (End of trading day)
Last (USD): 12.350 Change: +0.024 High: 12.350 Remarks: -
Change (%): +0.20 Low: 12.345

Company Background

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation service and to advance regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage; and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded on September 11, 1989 and is headquartered in Oldsmar, FL.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a 0.42494 Trailing EPS (USD) b 0.45964 NAV (USD) c 0.5626
PE a 29.063 Trailing PE d 26.869 Price / NAV c 21.9517
Dividend Yield (%) e - Cash In Hand (USD) f 0.9028 Issued & Paid-up Shares g 8,529,650
Piotroski F Score 7 Market Cap (M) 105.341 Free Float (%) -
Return on Equity (ROE) (%) h 81.699 Revenue Growth (%) TTM i -7.813
Net Earnings Growth (%) j 19.904 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 01 Oct 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.024
+0.19 %
10 Days -+0.010
+0.08 %
20 Days --0.130
-1.04 %
Medium Term Return 3 Months -+0.750
+6.47 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CRYO-CELL INTERNATIONAL INC NASDAQ 105.341 29.063 26.869 21.9517 -
Industry Medical Specialties NASDAQ 3,135.186 135.778 138.300 8.7029 0.025
Local Peer INTUITIVE SURGICAL INC NASDAQ 119,492.807 112.665 70.739 10.4718 -
Local Peer DEXCOM INC NASDAQ 55,343.431 112.122 104.560 25.9086 -
Local Peer IDEXX LABORATORIES INC NASDAQ 53,530.200 92.012 70.726 70.9238 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 50,029.926 28.172 67.604 14.2261 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 25,387.601 34.892 55.042 7.6528 -
Local Peer INSULET CORPORATION NASDAQ 20,405.355 3,000.710 - 40.9826 -
Local Peer HOLOGIC INC NASDAQ 19,100.453 10.206 10.206 4.5277 -
Local Peer MASIMO CORPORATION NASDAQ 15,919.864 66.249 68.603 10.8435 -
Local Peer ABIOMED INC NASDAQ 14,518.875 64.378 97.343 10.4863 -
Local Peer BRUKER CORPORATION NASDAQ 12,719.305 80.604 47.056 11.8253 0.191
Local Peer DENTSPLY SIRONA INC NASDAQ 10,643.975 - 25.495 2.0781 0.822
Local Peer NOVOCURE LTD NASDAQ 9,691.504 489.281 - 23.4565 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), SOTERA HEALTH CO (NASDAQ), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), STAAR SURGICAL CO (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), INARI MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CUE HEALTH INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), PULMONX CORPORATION (NASDAQ), CERUS CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), VIEWRAY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOVENTUS INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INTERCURE LTD (NASDAQ), INOGEN INC (NASDAQ), CUTERA INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), AIRSCULPT TECHNOLOGIES INC (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), 908 DEVICES INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), DERMTECH INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANTARES PHARMA INC (NASDAQ), IRADIMED CORP (NASDAQ), NYXOAH SA (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), SOLITON INC (NASDAQ), ZYNEX INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), AXOGEN INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVITA MEDICAL INC (NASDAQ), PAVMED INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), LUCID DIAGNOSTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEUROPACE INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CVRX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SIENTRA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), EARGO INC (NASDAQ), ONCOCYTE CORP (NASDAQ), QUOTIENT LTD (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), MINERVA SURGICAL INC (NASDAQ), TELA BIO INC (NASDAQ), CONFORMIS INC (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), INTRICOM CORP (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FONAR CORP (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), NEURONETICS INC (NASDAQ), IRIDEX CORP (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), LENSAR INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), NEPHROS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), IMMUCELL CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), ENVVENO MED CORP (NASDAQ), BIOMERICA INC (NASDAQ), CELSION CORPORATION (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), NUTRIBAND INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), NEUROMETRIX INC (NASDAQ), APPLIED UV INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), HEARTBEAM INC (NASDAQ), INSPIREMD INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), PETVIVO HLDGS INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DYNATRONICS CORP (NASDAQ), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ)
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 255,646.521 40.101 29.848 6.6041 0.137
Global Peer DANAHER CORP NYSE 233,323.682 66.474 40.777 5.8065 0.219
Global Peer ABBOTT LABORATORIES NYSE 226,394.169 50.614 31.391 6.5770 1.197
Global Peer MEDTRONIC PLC NYSE 148,311.161 41.129 38.195 2.8806 2.105
Global Peer STRYKER CORP NYSE 91,857.940 57.447 48.346 6.4789 0.964
Global Peer BECTON DICKINSON & CO NYSE 69,191.087 34.561 34.561 2.9223 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 69,120.017 83.944 46.788 12.4737 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,990.364 - 52.774 3.3404 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 46,443.763 64.595 46.913 9.3901 0.475
Global Peer ALCON AG NYSE 39,221.453 - 118.137 2.0542 0.133
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), PERKINELMER INC (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES